SEC Form 4 filings for TVM Life Science Ventures VI GmbH & Co KGTVM Life Science Ventures VI LPTVM Life Science Ventures VII L.P.Birner HubertMarengere LucFischer StefanSCHUHSLER HELMUTWanless MarkLeatt Gary,

Insider trading of Life Science Ventures Vi Gm..., a at ACER Acer Therapeutics Inc.

Most recently Life Science Ventures Vi Gm... bought 333,333 shares worth $3,999,996.00 on 12 December 2017.

Insider Title
Shares Price per share Total price Shares after Source
2017-12-12 Life Science Ventures Vi Gm...
Buy 333,333 $12.00 $3,999,996.00
1,422,709 SEC insider form 4
Acer Therapeutics Inc. logo

Acer Therapeutics Inc. develops therapies for the treatment of serious ultra-rare diseases with critical unmet medical needs. The company offers Celiprolol for vascular ehlers-danlos syndrome and ACER-001 for maple syrup urine disease (MSUD). It also offers advancing ACER-001 for the treatment of urea cycle disorders (UCD). The company was founded in 2013 and is based in Cambridge, Massachusetts.

  • Acer Therapeutics Inc., 222 Third Street, Cambridge 02142, United States
  • 844-902-6100